التفاصيل البيبلوغرافية
| العنوان: |
Pro-efferocytic nanotherapies reduce vascular inflammation without inducing anemia in a large animal model of atherosclerosis. |
| المؤلفون: |
Bamezai, Sharika, Zhang, Yapei, Kumari, Manisha, Lotfi, Mozhgan, Alsaigh, Tom, Luo, Lingfeng, Kumar, Gayatri Suresh, Wang, Fudi, Ye, Jianqin, Puri, Madhu, Manchanda, Romila, Paluri, Sesha, Adkar, Shaunak S., Kojima, Yoko, Ingelsson, Alice, Bell, Caitlin F., Lopez, Nicolas G., Fu, Changhao, Choi, Ryan B., Miller, Zach |
| المصدر: |
Nature Communications; 9/14/2024, Vol. 15 Issue 1, p1-13, 13p |
| مصطلحات موضوعية: |
ERYTHROCYTES, CD47 antigen, CARDIOVASCULAR diseases, NANOPARTICLES, CHEMICAL inhibitors |
| مستخلص: |
Atherosclerosis is an inflammatory disorder responsible for cardiovascular disease. Reactivation of efferocytosis, the phagocytic removal of cells by macrophages, has emerged as a translational target for atherosclerosis. Systemic blockade of the key 'don't-eat-me' molecule, CD47, triggers the engulfment of apoptotic vascular tissue and potently reduces plaque burden. However, it also induces red blood cell clearance, leading to anemia. To overcome this, we previously developed a macrophage-specific nanotherapy loaded with a chemical inhibitor that promotes efferocytosis. Because it was found to be safe and effective in murine studies, we aimed to advance our nanoparticle into a porcine model of atherosclerosis. Here, we demonstrate that production can be scaled without impairing nanoparticle function. At an early stage of disease, we find our nanotherapy reduces apoptotic cell accumulation and inflammation in the atherosclerotic lesion. Notably, this therapy does not induce anemia, highlighting the translational potential of targeted macrophage checkpoint inhibitors. Systemic blockade of CD47 showed promising results for treating atherosclerosis but induces anemia. Here, the authors show that macrophage-specific nanoparticles promoting efferocytosis reduce apoptotic cell accumulation and inflammation in a porcine model of atherosclerosis without causing anemia. [ABSTRACT FROM AUTHOR] |
|
Copyright of Nature Communications is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Find this article in full text from Springer Verlag. 
Full Text Finder